Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism

Clinical Endocrinology

Volumn 65, Issue 4, 2006, Pages 530-535

  Altinova, Alev E ^a   Törüner, Füsun B ^a   Aktürk, Müjde ^a   Bukan, Neslihan ^a   Çakir, Nuri ^a   Ayvaz, Göksun ^a   Arslan, Metin ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN A; APOLIPOPROTEIN B; C REACTIVE PROTEIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LIPID; THYROID HORMONE;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; EUTHYROIDISM; FEMALE; HOMEOSTASIS; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; THYROID DISEASE;

ADIPONECTIN; ADULT; APOLIPOPROTEINS B; APOPROTEIN(A); BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; FEMALE; FIBRINOGEN; HOMOCYSTEINE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; INSULIN RESISTANCE; LIPOPROTEIN(A); MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 33748768713     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02628.x     Document Type: Article

References (43)

1. Nakano, Y., Tobe, T., Choi-Miura, N.H., Mazda, T. & Tomita, M. (1996) Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. Journal of Biochemistry, 120, 803-812.
2. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., Kuriyama, H., Nishida, M., Yamashita, S., Okubo, K., Matsubara, K., Muraguchi, M., Ohmoto, Y., Funahashi, T. & Matsuzawa, Y. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemistry and Biophysics Research Communications, 257, 79-83.
3. Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R.E. & Tataranni, P.A. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism, 86, 1930-1935.
4. Matsubara, M., Maruoka, S. & Katayose, S. (2002) Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. European Journal of Endocrinology, 147, 173-180.
5. Diez, J.J. & Iglesias, P. (2003) The role of the novel adipocyte-derived hormone adiponectin in human disease. European Journal of Endocrinology, 148, 293-300.
6. Fernandez-Real, J.M., Lopez-Bermejo, A., Casamitjana, R. & Ricart, W. (2003) Novel interactions of adiponectin with the endocrine system and inflammatory parameters. Journal of Clinical Endocrinology and Metabolism, 88, 2714-2718.
7. Matsuda, M., Shimomura, I., Sata, M., Arita, Y., Nishida, M., Maeda, N., Kumada, M., Okamoto, Y., Nagaretani, H., Nishizawa, H., Kishida, K., Komuro, R., Ouchi, N., Kihara, S., Nagai, R., Funahashi, T. & Matsuzawa, Y. (2002) Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. Journal of Biological Chemistry, 277, 37487-37491.
8. Kumada, M., Kihara, S., Sumitsuji, S., Kawamoto, T., Matsumoto, S., Ouchi, N., Arita, Y., Okamoto, Y., Shimomura, I., Hiraoka, H., Nakamura, T., Funahashi, T. & Matsuzawa, Y. (2003) Osaka CAD Study Group. Coronary artery disease. Association of hypoadiponectinemia with coronary artery disease in men. Arteriosclerosis Thrombosis and Vascular Biology, 23, 85-89.
9. Duntas, L.H. (2002) Thyroid disease and lipids. Thyroid, 12, 267-293.
10. Diekman, T., Demacker, P.N., Kastelein, J.J., Stalenhoef, A.F. & Wiersinga, W.M. (1998) Increased oxidizability of low-density lipoproteins in hypothyroidism. Journal of Clinical Endocrinology and Metabolism, 83, 1752-1755.
11. Sundaram, V., Hanna, A.N., Koneru, L., Newman, H.A. & Falko, J.M. (1997) Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. Journal of Clinical Endocrinology and Metabolism, 82, 3421-3424.
12. Bech, K., Damsbo, P., Eldrup, E., Beck-Nielsen, H., Roder, M.E., Hartling, S.G., Volund, A. & Madsbad, S. (1996) Beta-cell function and glucose and lipid oxidation in Graves' disease. Clinical Endocrinology, 44, 59-66.
13. Tene, C., Zarate, A., Basurto, L., Islas, S., Revilla, C., Ochoa, R., Galvan, R. & Santos, P. (2001) Correction of insulin resistance in methimazole-treated patients with Graves disease. Revista de Investigacion Clinica, 53, 531-535.
14. Danesh, J., Whincup, P., Walker, M., Lennon, L., Thomson, A., Appleby, P., Gallimore, J.R. & Pepys, M.B. (2000) Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. British Medical Journal, 321, 199-204.
15. Ridker, P.M. (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation, 107, 363-369.
16. Christ-Crain, M., Meier, C., Guglielmetti, M., Huber, P.R., Riesen, W., Staub, J.J. & Muller, B. (2003) Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis, 166, 379-386.
17. Nedrebo, B.G., Ericsson, U.B., Nygard, O., Refsum, H., Ueland, P.M., Aakvaag, A., Aanderud, S. & Lien, E.A. (1998) Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism, 47, 89-93.
18. Caraccio, N., Ferrannini, E. & Monzani, F. (2002) Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. Journal of Clinical Endocrinology and Metabolism, 87, 1533-1538.
19. de Bruin, T.W., van Barlingen, H., van Linde-Sibenius Trip, M., van Vuurst de Vries, A.R., Akveld, M.J. & Erkelens, D.W. (1993) Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects. Journal of Clinical Endocrinology and Metabolism, 76, 121-126.
20. Chadarevian, R., Bruckert, E., Giral, P. & Turpin, G. (1999) Relationship between thyroid hormones and fibrinogen levels. Blood Coagulation and Fibrinolysis, 10, 481-486.
21. Yoda, M., Nakano, Y., Tobe, T., Shioda, S., Choi-Miura, N.H. & Tomita, M. (2001) Characterization of mouse GBP28 and its induction by exposure to cold. International Journal of Obesity and Related Metabolic Disorders, 25, 75-83.
22. Stefan, N., Vozarova, B., Funahashi, T., Matsuzawa, Y., Weyer, C., Lindsay, R.S., Youngren, J.F., Havel, P.J., Pratley, R.E., Bogardus, C. & Tataranni, P.A. (2002) Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes, 51, 1884-1888.
23. Bakker, S.J., ter Maaten, J.C., Popp-Snijders, C., Slaets, J.P., Heine, R.J. & Gans, R.O. (2001) The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. Journal of Clinical Endocrinology and Metabolism, 86, 1206-1211.
24. Yaturu, S., Prado, S. & Grimes, S.R. (2004) Changes in adipocyte hormones leptin, resistin, and adiponectin in thyroid dysfunction. Journal of Cellular Biochemistry, 93, 491-496.
25. Iglesias, P., Alvarez-Fidalgo, P., Codoceo, R. & Diez. J.J. (2003) Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clinical Endocrinology, 59, 621-629.
26. Santini, F., Marsili, A., Mammoli, C., Valeriano, R., Scartabelli, G., Pelosini, C., Giannetti, M., Centoni, R., Vitti, P. & Pinchera, A. (2004) Serum concentrations of adiponectin and leptin in patients with thyroid dysfunctions. Journal of Endocrinological Investigation, 27, RC5-7.
27. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner. & R.C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
28. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., Ezaki, O., Akanuma, Y., Gavrilova, O., Vinson, C., Reitman, M.L., Kagechika, H., Shudo, K., Yoda, M., Nakano, Y., Tobe, K., Nagai, R., Kimura, S., Tomita, M., Froguel, P. & Kadowaki, T. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine, 7, 941-946.
29. Ouchi, N., Kihara, S., Arita, Y., Nishida, M., Matsuyama, A., Okamoto, Y., Ishigami, M., Kuriyama, H., Kishida, K., Nishizawa, H., Hotta, K., Muraguchi, M., Ohmoto, Y., Yamashita, S., Funahashi, T. & Matsuzawa, Y. (2001) Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation, 103, 1057-1063.
30. Ridker, P.M., Hennekens, C.H., Buring, J.E. & Rifai, N. (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New England Journal of Medicine, 342, 836-843.
31. Libby, P., Ridker, P.M. & Maseri, A. (2002) Inflammation and atherosclerosis. Circulation, 105, 1135-1143.
32. Ouchi, N., Kihara, S., Funahashi, T., Nakamura, T., Nishida, M., Kumada, M., Okamoto, Y., Ohashi, K., Nagaretani, H., Kishida, K., Nishizawa, H., Maeda, N., Kobayashi, H., Hiraoka, H. & Matsuzawa, Y. (2003) Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation, 107, 671-674.
33. Engeli, S., Feldpausch, M., Gorzelniak, K., Hartwig, F., Heintze, U., Janke, J., Mohlig, M., Pfeiffer, A.F., Luft, F.C. & Sharma, A.M. (2003) Association between adiponectin and mediators of inflammation in obese women. Diabetes, 52, 942-947.
34. Krakoff, J., Funahashi, T., Stehouwer, C.D., Schalkwijk, C.G., Tanaka, S., Matsuzawa, Y., Kobes, S., Tataranni, P.A., Hanson, R.L., Knowler, W.C. & Lindsay, R.S. (2003) Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care, 26, 1745-1751.
35. Chadarevian, R., Bruckert, E., Leenhardt, L., Giral, P., Ankri, A. & Turpin, G. (2001) Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. Journal of Clinical Endocrinology and Metabolism, 86, 732-737.
36. Diekman, M.J., van der Put, N.M., Blom, H.J., Tijssen, J.G. & Wiersinga, W.M. (2001) Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism. Clinical Endocrinology, 54, 197-204.
37. Erem, C., Ersoz, H.O., Karti, S.S., Ukinc, K., Hacihasanoglu, A., Deger, O. & Telatar, M. (2002) Blood coagulation and fibrinolysis in patients with hyperthyroidism. Journal of Endocrinological Investigation, 25, 345-350.
38. Marongiu, F., Conti, M., Murtas, M.L., Mameli, G., Sorano, G.G. & Martino, E. (1991) Activation of blood coagulation and fibrinolysis in Graves' disease. Hormone and Metabolic Research, 23, 609-611.
39. Yamamoto, Y., Hirose, H., Saito, I., Tomita, M., Taniyama, M., Matsubara, K., Okazaki, Y., Ishii, T., Nishikai, K. & Saruta, T. (2002) Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clinical Science, 103, 137-142.
40. Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., Murakami, K., Ohteki, T., Uchida, S., Takekawa, S., Waki, H., Tsuno, N.H., Shibata, Y., Terauchi, Y., Froguel, P., Tobe, K., Koyasu, S., Taira, K., Kitamura, T., Shimizu, T., Nagai, R. & Kadowaki, T. (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 423, 762-769.
41. Schneider, J.G., von Eynatten, M., Schiekofer, S., Nawroth, P.P. & Dugi, K.A. (2005) Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. Diabetes Care, 28, 2181-2186.
42. Kukkonen-Harjula, K.T., Borg, P.T., Nenonen, A.M. & Fogelholm, M.G. (2005) Effects of a weight maintenance program with or without exercise on the metabolic syndrome: a randomized trial in obese men. Preventive Medicine, 41, 784-790.
43. Bruun, J.M., Helge, J.W., Richelsen, B. & Stallknecht, B. (2006) Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. American Journal of Physiology. Endocrinology and Metabolism, 290, E961-967.